Weight loss drugs could save airlines money on fuel as Americans shed pounds
As obesity rates among Americans drop and weight loss drugs lead to a slimmer society, airlines could save on fuel costs, according to a recent analysis.
Weight Loss
"Enough": Oprah Winfrey on her weight-loss lessons
For years, she seemed powerless against a fluctuating weight problem, until new medications, and a new attitude, gave Oprah Winfrey a breakthrough. She talks with Jane Pauley about "Enough," a new book co-written with Dr. Ania Jastreboff, about her weight-loss success.
Book excerpt: "Enough" by Dr. Ania Jastreboff and Oprah Winfrey
The media superstar, who has struggled with weight for much of her life, and a Yale School of Medicine doctor team up for a book that examines the biology of obesity, offering a new way forward.
"Enough": Oprah Winfrey on her weight-loss lessons
Oprah Winfrey is one of the best-known, most-admired and successful people on the planet. But for years she seemed powerless to conquer her fluctuating weight problem … until new medications, and a new attitude about her weight, gave her a breakthrough, which she describes in "Enough," a new book she has co-written with Dr. Ania Jastreboff. They talk with Jane Pauley about an individual's genetically-influenced weight range, and how to reset it. Winfrey also relates the long road she traveled since she began her TV career in Nashville, facing sexism, racism, and comments about her weight.
New study on stopping weight loss drugs
Popular weight loss drugs like GLP-1 injections are helping millions of people lose pounds. But a new study shows that stopping these medications can cause the weight to rapidly come back and reverse positive health effects. CBS News medical contributor Dr. Céline Gounder has more.
Impact of stopping use of weight loss drugs
New research suggests that after stopping the use of weight loss drugs, weight regain is almost four times faster compared to after traditional diet and physical exercise programs. CBS News medical contributor Dr. Celine Gounder explains what the study found.
Novo Nordisk debuts Wegovy weight-loss pill in the U.S.
FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.
Details on FDA-approved GLP-1 pill for weight loss
The FDA has approved the first GLP-1 pill for weight loss and it's expected in pharmacies in the coming weeks. Dr. Holly Lofton, director of the Medical Weight Management Program at NYU Langone, joins CBS News to discuss.
FDA approves Wegovy pill for weight loss
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
FDA approves Wegovy pill for weight loss
The FDA has approved the pill version of the weight loss drug Wegovy, the first oral medication of its kind. The new pills are expected to be available in a few weeks. Chief medical correspondent Dr. Jon LaPook has more.
How GLP-1 drugs are shifting consumer habits
The rise in the use of GLP-1 weight-loss drugs across the U.S. is shifting not only scales, but also how Americans are spending their time and money. Washington Post retail reporter Jaclyn Peiser explains.
GLP-1 drugs and muscle loss: What to know
A recent KFF poll revealed that one in eight adults in the U.S. is currently taking a GLP-1 weight loss drug. As more people start using them, some are talking about the unexpected side effects, including muscle loss and weakness. Senior Vox correspondent Dylan Scott joins CBS News to share what patients told him.
Could pets be next for weight loss drugs? Here's what to know about a study.
A clinical study into weight loss drugs for pets just launched, with results from the trial expected by next summer.
Can weight loss drugs be used for pets?
Experts say roughly six in 10 cats in the U.S. are carrying too much weight. A new clinical trial, "MEOW-1," could change that, testing to see if GLP-1 weight loss drugs can be used on pets. Ash-har Quraishi reports.
Company studying GLP-1s for cats
Weight loss drugs for Americans have skyrocketed to success. Now, the GLP-1 frenzy could be heading to a new frontier: your pets. A San Francisco biopharmaceutical company says it is conducting a pilot study on a GLP-1 drug for cats with obesity. Okava CEO Michael Klotsman joins CBS News to discuss.
Details on lower weight loss drugs prices
President Trump announced a deal on Thursday that will lower the cost of some weight loss drugs for certain eligible Americans. CBS News medical contributor Dr. Celine Gounder explains the details of the deal and how much Americans can expect to pay.
Trump announces deal to lower weight loss drug prices in some cases
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
Doctor on lowering weight loss drug costs
President Trump announced a deal with Eli Lilly and Novo Nordisk on Thursday to lower the cost of their weight loss drugs for some Americans. Dr. Holly Lofton, NYU Langone Medical's weight management program director, joins "The Daily Report" to discuss.
Novo Nordisk CEO on Trump drug prices deal
President Trump on Thursday unveiled agreements slashing the prices of two pharmaceutical companies' weight loss drugs. Novo Nordisk CEO Mike Doustdar joins "The Takeout" to unpack the cost-cutting effort.
Deal could lower cost of weight loss drugs
Some people on weight loss drugs may be able to get them at a much lower cost next year after President Trump announced a new deal on Thursday with the drug makers of certain GLP-1s. CBS News senior White House and political correspondent Ed O'Keefe reports.
Doctor discusses weight-loss drug deals
The Trump administration announced Thursday a deal to lower the price of weight loss drugs for some Americans. Dr. Bayo Curry-Winchell, founder of Beyond Clinical Walls, joins CBS News 24/7 to discuss the news.
Trump on slashing weight loss drug prices
President Trump announced Thursday a deal with Eli Lilly and Novo Nordisk to reduce prices for popular weight loss drugs for some Americans. CBS News' Aaron Navarro has more.
Trump announces deal to lower drug prices
President Trump announced a deal to lower the price of weight loss drugs for some Americans. CBS News' Jennifer Jacobs has more.
Obesity rate is declining as more Americans use weight loss drugs, survey finds
As more Americans turn to weight loss drugs, the U.S. adult obesity rate is declining, according to new survey data from Gallup.
Costco to sell weight loss drugs
Shoppers can now find Ozempic and Wegovy at Costco. It says it is partnering with drugmaker Novo Nordisk to offer the drugs at a steep discount for members with a prescription. CBS News reporter Andres Gutierrez has more.
Live
Trump confirms "major combat operations" as U.S. and Israel attack Iran
The U.S. and Israel are attacking Iran, which is responding with attacks on U.S. bases in the region, as President Trump confirms "major combat operations."
Read Trump's full statement on U.S. "major combat operations" in Iran
President Trump says his objective in attacking Iran "is to defend the American people by eliminating imminent threats" from the regime in Tehran. Read his full statement here.
Exclusive
Anthropic CEO says he's sticking to AI "red lines" despite clash with Pentagon
After the Trump administration cut it off, Anthropic CEO Dario Amodei told CBS News in an exclusive interview Friday night he wants to work with the military — but only if it addresses the firm's concerns.
How advanced is Iran's nuclear program? Here's what we know.
President Trump launched military strikes on Iran after several rounds of talks over the country's nuclear program and uranium stockpiles. Here's what to know about the nuclear program.
Trump orders federal agencies to stop using Anthropic's AI technology
President Trump said he will give federal agencies six months to phase out their use of Anthropic's AI products.
Renee Good's family spent "hours in limbo" after she was fatally shot
Renee Good's family said they spent agonizing "hours in limbo," unsure of the details surrounding her fatal shooting by a U.S. Immigration and Customs Enforcement officer in Minneapolis last month.
Bill Clinton at Epstein deposition: "I saw nothing, and I did nothing wrong"
Former President Bill Clinton denied any knowledge of Jeffrey Epstein's crimes in an opening statement before the House Oversight Committee in New York.
Neil Sedaka, singer whose hits included "Laughter in the Rain," dies at 86
Singer-songwriter Neil Sedaka, known for his hits like "Laughter in the Rain," "Breaking Up is Hard to Do" and "Calendar Girl," has died.
Hegseth declares Anthropic a "supply chain risk to national security"
Defense Secretary Pete Hegseth deemed artificial intelligence firm Anthropic a supply chain risk on Friday, following days of increasingly heated public conflict with the AI company.
U.S.
More U.S.
Anthropic CEO Dario Amodei calls White House's actions "retaliatory and punitive"
Hours before Anthropic CEO Dario Amodei's interview, Defense Secretary Pete Hegseth deemed the AI company a "supply chain risk to national security," which restricts military contractors from doing business with Anthropic.
A Hawaii man tackled his sports gambling addiction by offering free surf lessons
For Buddy Wiggins of Honolulu, Hawaii, the end result of a yearslong sports gambling addiction has come to this: soliciting strangers on the beach.
Renee Good's family spent "hours in limbo" after she was fatally shot
Renee Good's family said they spent agonizing "hours in limbo," unsure of the details surrounding her fatal shooting by a U.S. Immigration and Customs Enforcement officer in Minneapolis last month.
10 Epstein files conspiracy theories, debunked
Conspiracy theories about the Epstein files have racked up millions of views on social media. Here's what to know about 10 of the most viral claims.
Robots, already in hospitals, are ready to roll in other industries
In the years to come, robots will help offset worker shortages in health care, manufacturing and other industries, experts say.
MoneyWatch
More MoneyWatch
Exclusive
Anthropic CEO says he's sticking to AI "red lines" despite clash with Pentagon
After the Trump administration cut it off, Anthropic CEO Dario Amodei told CBS News in an exclusive interview Friday night he wants to work with the military — but only if it addresses the firm's concerns.
Hegseth declares Anthropic a "supply chain risk to national security"
Defense Secretary Pete Hegseth deemed artificial intelligence firm Anthropic a supply chain risk on Friday, following days of increasingly heated public conflict with the AI company.
Robots, already in hospitals, are ready to roll in other industries
In the years to come, robots will help offset worker shortages in health care, manufacturing and other industries, experts say.
Book excerpt: "Streetwise" by Lloyd Blankfein
In his new memoir, the former CEO of Goldman Sachs writes about a life that stretched from the projects of New York City to the pinnacle of Wall Street.
Small business owner is already giving her customers a tariff refund
"If somebody charges you something and it's unlawful, they should give you your money back," Dame CEO Alexandra Fine said.
Politics
More Politics
Exclusive
Read the full transcript of our interview with Anthropic CEO Dario Amodei
Anthropic CEO Dario Amodei sat down with CBS News for an exclusive interview Friday, hours after Defense Secretary Pete Hegseth declared the company a supply chain risk to national security.
Tejano music star boosted by late outside spending for his Texas congressional campaign
A Democratic primary in a GOP held Texas congressional district is seeing major money ahead of polls closing in the March 3 contest.
Exclusive
Anthropic CEO says he's sticking to AI "red lines" despite clash with Pentagon
After the Trump administration cut it off, Anthropic CEO Dario Amodei told CBS News in an exclusive interview Friday night he wants to work with the military — but only if it addresses the firm's concerns.
See Trump's full statement on U.S. "major combat operations" in Iran
President Trump says his objective in attacking Iran "is to defend the American people by eliminating imminent threats" from the regime in Tehran. Read his full statement and watch the video here.
Live
Trump confirms "major combat operations" as U.S. and Israel attack Iran
The U.S. and Israel are attacking Iran, which is responding with attacks on U.S. bases in the region, as President Trump confirms "major combat operations."
HealthWatch
More HealthWatch
Medicaid is paying for more dental care. GOP cuts threaten to reverse the trend.
More than three dozen states cover dental services for people on Medicaid, but with about $900 billion in cuts expected to hit states over the next decade, many programs could roll back dental coverage.
Health premiums threaten their nest egg. A terminal diagnosis may spare it.
Chaz and Jean Franklin were facing a sevenfold increase in their health premium payments with the expiration of enhanced federal subsidies for Affordable Care Act plans. Then Jean received a crushing diagnosis.
Could "kidulting" be the way to take the work out of your workout?
A British gym chain is offering classes in "kidulting," luring adults into fitness with classes built around playground and PE class classics.
Novo Nordisk to slash Wegovy and Ozempic prices starting in 2027
Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.
As more Americans embrace anxiety treatment, RFK Jr. derides medications
Robert F. Kennedy Jr. has criticized the broadening use of anxiety medications, but doctors and researchers say the MAHA movement is misrepresenting drugs that have been proven to help.
World
More World
See Trump's full statement on U.S. "major combat operations" in Iran
President Trump says his objective in attacking Iran "is to defend the American people by eliminating imminent threats" from the regime in Tehran. Read his full statement and watch the video here.
Live
Trump confirms "major combat operations" as U.S. and Israel attack Iran
The U.S. and Israel are attacking Iran, which is responding with attacks on U.S. bases in the region, as President Trump confirms "major combat operations."
Israel launches "preemptive strike" on Iran, Israeli military says
The Israel Defense Ministry said in a statement that it launched the strike because it was expecting "a missile and drone attack" from Iran "in the immediate future."
More than a dozen killed when plane carrying money crashes in Bolivia, official says
The plane belonging to the Bolivian air force was transporting new banknotes from Bolivia's Central Bank to other cities. A large number of bills were scattered on the ground at the crash site.
U.S.-Iran deal is "within our reach," Omani mediator says
Negotiators from the U.S. and Iran have made "substantial progress" toward a deal to curb Iran's nuclear program, Omani Foreign Minister Badr Albusaidi told CBS News on Friday.
Entertainment
More Entertainment
Entertainment
From the archives: Neil Sedaka on writing a hit song
Neil Sedaka, the singer and songwriter behind such hits as "Breaking Up is Hard to Do," "Calendar Girl," and "Love Will Keep Us Together," died on Friday, Feb. 27, 2026 at age 86. In this 2020 "Sunday Morning" story, David Pogue talked with Sedaka – as well as Valerie Simpson (of Ashford & Simpson), author John Seabrook, and producer Oak Felder – about the elements that go into writing a hit song.
Neil Sedaka, singer whose hits included "Laughter in the Rain," dies at 86
Singer-songwriter Neil Sedaka, known for his hits like "Laughter in the Rain," "Breaking Up is Hard to Do" and "Calendar Girl," has died.
Book excerpt: "Never Mind the Happy" by Marc Shaiman
In his memoir, the Tony Award-winning composer of such hits as Broadway's "Hairspray" writes of his half-century in show business, which grew in part from his youthful worship of Bette Midler - an adoration that would grow into a collaboration.
"Sinners" composer on blues music journey
For Oscar-winning composer Ludwig Goransson, creating the score for "Sinners" was a challenge, explaining he had to find his "voice within the blues." He describes his unlikely personal connection to the music and how he met the film's director.
"Scream" creator on directing latest movie
"Scream" writer and creator Kevin Williamson describes his passion for horror films and being asked to direct a "Scream" movie for the first time, at the request of one of the returning stars. Natalie Morales reports.
Technology
More Technology
Exclusive
Anthropic CEO says he's sticking to AI "red lines" despite clash with Pentagon
After the Trump administration cut it off, Anthropic CEO Dario Amodei told CBS News in an exclusive interview Friday night he wants to work with the military — but only if it addresses the firm's concerns.
Anthropic CEO on "punitive" Pentagon action
In an exclusive interview with CBS News, Anthropic CEO Dario Amodei said that the Pentagon's decision to designate the AI company a supply chain risk is "retaliatory and punitive." The Pentagon made the designation, which restricts military contractors from doing business with Anthropic, after the company refused to give the military unfettered access to its AI model.
How AI powered robots are helping small farms
From labor shortages to environmental impacts, farmers are looking to AI to help revolutionize the agriculture industry. One California startup, Farm-ng, is tapping into the power of AI and robotics to perform a wide range of tasks, including seeding, weeding and harvesting.
Full interview: Anthropic CEO Dario Amodei
Anthropic CEO Dario Amodei sat down with CBS News for an exclusive interview, hours after Defense Secretary Pete Hegseth declared the company a supply chain risk to national security, which restricts military contractors from doing business with the AI giant. Amodei called the move "retaliatory and punitive," and he said Anthropic sought to draw "red lines" in the government's use of its technology because "we believe that crossing those lines is contrary to American values, and we wanted to stand up for American values."
Anthropic CEO on "red lines" for AI military use
Anthropic CEO Dario Amodei said in an exclusive interview with CBS News that the AI company sought to draw "red lines" in the government's use of its technology because "we believe that crossing those lines is contrary to American values, and we wanted to stand up for American values." He added: "Disagreeing with the government is the most American thing in the world."
Science
More Science
NASA announces major overhaul of Artemis moon program "to take down risk"
NASA Administrator Jared Isaacman announced significant changes to the agency's Artemis program, which aims to land on the moon in 2028.
What scientists will be looking for when government UFO files are released
Documents might help scientists shed light on unexplained phenomena and government secrets, experts said.
In a first, shark seen on camera in Antarctica waters, surprising researchers
A large shark was caught on camera for the first time in Antarctica's waters, surprising researchers. "There's a general rule of thumb that you don't get sharks in Antarctica," one said.
How Washington's crossing of the Delaware presaged a changing world
On the evening of Christmas 1776, Gen. George Washington surprised the King's forces by leading the Continental Army in a surprise crossing of a near-frozen Delaware River - a watershed military maneuver that dramatized a changing America, and a changing climate.
These United States: George Washington and climate change
On the evening of Christmas 1776, Gen. George Washington surprised the King's forces by leading the Continental Army in an unanticipated crossing of a near-frozen Delaware River. Environmental correspondent David Schechter looks at how Washington's watershed military maneuver dramatized both a changing America, and a changing climate.
Crime
More Crime
Crime
Bill Clinton opening statement for deposition
Former President Bill Clinton is being deposed by members of the House Oversight Committee over his alleged links to Jeffrey Epstein. CBS News' Nikole Killion reports.
Did ICE lie before detaining NYC student?
Columbia University acting president Claire Shipman described the ICE detention of student Elmina "Ellie" Aghayeva, claiming agents gained entry to a residential building by stating they were police seeking a missing child. CBS News' Tom Hanson reports.
Bill Clinton's turn for Epstein deposition
Former President Bill Clinton is up next for a deposition before members of the House Oversight Committee regarding his alleged links to convicted sex offender Jeffrey Epstein. CBS News' Nikole Killion reports.
Latest news Columbia student taken by ICE
Columbia University student Elmina Aghayeva has been released after ICE took her from one of the institution's residential buildings. CBS News' Tom Hanson reports.
Epstein files questionings continue
Kentucky Republican Rep. James Comer, the chairman of the House Committee on Oversight and Accountability, said Commerce Secretary Howard Lutnick may be asked to testify on his knowledge of convicted sex offender Jeffrey Epstein's dealings. This comes as former President Bill Clinton prepares for his deposition. CBS News' Nikole Killion reports.
Space
More Space
Space
Why NASA is overhauling Artemis program
NASA has announced a major overhaul of its Artemis moon program amid ongoing safety concerns. CBS News space consultant Bill Harwood has more details.
How NASA plans to get astronauts on the moon
NASA announced an overhaul to its Artemis moon program as safety concerns persist. CBS News space contributor Christian Davenport breaks down the key takeaways.
NASA announces major overhaul of Artemis moon program "to take down risk"
NASA Administrator Jared Isaacman announced significant changes to the agency's Artemis program, which aims to land on the moon in 2028.
Safety concerns over NASA's Artemis program
NASA's Artemis II mission continues to face concerns and delays. Scott E. Parazynski, a former astronaut, joins CBS News with more.
NASA rolls Artemis II back for repairs
NASA is rolling back the Artemis II moon rocket from its launch pad at the Kennedy Space Center in Florida. It is expected to take up to 12 hours to move the 322-foot rocket, with the journey spanning four miles back to its hangar for repairs. CBS News space consultant Bill Harwood has more.
Latest Galleries
More Latest Galleries
Notable Deaths in 2026
A look back at the esteemed personalities who've left us this year, who'd touched us with their innovation, creativity and humanity.
Evidence in the Barbara Kendhammer case
Does the evidence show a cover-up, or was Todd Kendhammer wrongfully convicted for the murder of his wife?
The life & near death of prizefighter Christy Salters-Martin
Christy Salters-Martin dominated in the boxing ring but faced her toughest challenger at home.
Timeline: The disappearance of George Smith
Family seeks answers in death of newlywed who disappeared in 2005 while on Mediterranean honeymoon cruise.
Who is Alix Tichelman?
Meet the tattooed beauty charged in the death of Google executive Forrest Hayes.
Latest CBS News Videos
More Latest CBS News Videos
Latest CBS News Videos
Trump's full statement on Iran strikes
President Trump announced early Saturday morning that the U.S. is conducting "a massive and ongoing operation to prevent this very wicked, radical dictatorship from threatening America and our core national security interests." See his full remarks.
U.S. and Israel launch strikes against Iran
The U.S. and Israel carried out military strikes on targets in Iran early Saturday after President Trump threatened the Iranian regime for weeks to make a new deal to rein in its nuclear program, and before that, threatened it over its violent crackdown on protesters in January. Carissa Lawson anchors CBS News' special report.
Trump speaks as U.S. launches Iran strikes
President Trump said the U.S. military has begun "major combat operations in Iran" in a statement released early Saturday morning. Mr. Trump threatened the Iranian regime for weeks to make a new deal to rein in its nuclear program, and before that, threatened it over its violent crackdown on protesters in January.
Anthropic CEO on "punitive" Pentagon action
In an exclusive interview with CBS News, Anthropic CEO Dario Amodei said that the Pentagon's decision to designate the AI company a supply chain risk is "retaliatory and punitive." The Pentagon made the designation, which restricts military contractors from doing business with Anthropic, after the company refused to give the military unfettered access to its AI model.
Full interview: Anthropic CEO Dario Amodei
Anthropic CEO Dario Amodei sat down with CBS News for an exclusive interview, hours after Defense Secretary Pete Hegseth declared the company a supply chain risk to national security, which restricts military contractors from doing business with the AI giant. Amodei called the move "retaliatory and punitive," and he said Anthropic sought to draw "red lines" in the government's use of its technology because "we believe that crossing those lines is contrary to American values, and we wanted to stand up for American values."